Impact factor of theranostics
WitrynaImpact factor 11.600 ISSN: 1838-7640 Theranostics . Home ; Aims and scope ; Editorial board ; Author info ; ... Theranostics 2024; 11(19): ... Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis WitrynaExtracellular vesicles (EVs) mediate cell interactions in biological processes, such as receptor activation or molecule transfer. Estimates of variation by age and sex have been limited by small sample size, and no report has assessed the contribution of genetic factors to levels of EVs. Here, we evaluated blood levels of 25 EV and 3 platelet traits …
Impact factor of theranostics
Did you know?
WitrynaTheranostics is an amalgamation of diagnostic biomarkers and therapeutic medicines that have a shared target in damaged cells or tissues. Different theranostic … WitrynaTheranostics is a novel concept which involves the integration of diagnosis and therapy in a single platform using nanomaterials. Nanotheranostics is a promising combination of multidisciplinary fields like chemistry, physics, material sciences, nanotechnology, drug delivery, and pharmacology.
Witryna3 lip 2013 · With the newly released impact factor from Thomson Reuters, we look at the first two years of the journal Theranostics under the scope of a new bibliometric … WitrynaTheranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, … Aims and Scope. The aim of Theranostics is to provide a forum for the exchange of … Editorial board - Theranostics Theranostics accepts original scientific and review articles. Letters commenting on … Submit manuscript - Theranostics Contact - Theranostics Impact factor 11.600 ISSN: 1838-7640 Theranostics. Home ; Aims and scope ; … Previous issue Next issue Archive . Volume 13 (6); 2024. Editorial. A novel … Theranostics Archive of Vols. 1-13; 2011-2024. v.13(4) Cover PDF v.13(4) …
WitrynaThe latest impact factor of Theranostics and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, researchers can check the … WitrynaImpact Factor: 11.6. Citescore: 16.7. SCIMAGO SJR: 2.061. SCIMAGO H-index: 115. Research Ranking (Medicine) 272. Number of Best scientists*: 312. Documents by …
Witryna27 maj 2024 · The impact score (IS) 2024 of Theranostics is 10.71, which is computed in 2024 as per its definition.Theranostics IS is increased by a factor of 0.04 and …
WitrynaImpact factor 11.600 ISSN: 1838-7640 Theranostics . Home ; Aims and scope ... IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8 ... Marc Charabati, Alexandre Prat, Cecilia Garlanda, Elan Z. Eisenmesser, Charles A. Dinarello, Rubèn López-Vales Theranostics 2024; … ct-3031ct-303.5Witryna2 dni temu · Dissolution from mesoporous drug delivery system is a very complex process, which can be affected by various factors, including mesoporous structure, pore size, surface functionalization, drug-mesoporous surface interaction, etc. McCarthy et al. investigated the effects of the porous architecture of mesoporous SBA-15 and non … ct 308WitrynaImpact Factor: 1.109 (2024-20) 1.209 (2024-21) Ingress Full text Author Guidelines Submit Your Paper Open Access Propose Special Issue Recommend to Librarian Editor Registrations Indexing & Archiving Order Reprints Pay Online. Pubmed Indexed Articles. ct-30220WitrynaA broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Papers in the journal are rigorously peer-reviewed. ct-3030aWitrynaNanoparticle-based systems in recent decades have been employed for tumor diagnostics and therapy (i.e., theranostics) [].However, although numerous approaches have been followed to enhance the retention of nanocarriers in the tumor site, few have shown significant success, as the tumor harbors a vascular barrier system … ear pain after wearing headphonesWitrynaThe aim of Theranostics is to provide a forum for the exchange of clinical and scientific information for the diagnostic and therapeutic molecular and nano medicine … ct30p-30t260